Loading...

Mankind Pharma Limited IPO (Mankind Pharma IPO) Detail

Apr 25, 2023 - Apr 27, 2023

Incorporated in 1991, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products.

In India, the business is active in a number of acute and chronic therapeutic fields, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory.

It has over 36 brands, including Manforce (Rx), Moxikind-CV, Amlokind-AT, Unwanted-Kit, Candiforce, Gudcef, Glimestar-M, Prega News, Dydroboon, Codistar, Nurokind-Gold, Nurokind Plus-RF, Nurokind-LC, Asthakind-DX, Cefakind, Monticope, Telmikind-H, Telmikind, Gudcef-CV, and Unwanted-72, among them.

Mankind Pharma has one of the largest distribution networks of medical representatives in the Indian pharmaceutical market. Over 80% of doctors in India prescribed their formulations and has been ranked number 4th in terms of domestic sales during the Financial Year 2022.

The company has earned numerous awards and recognitions and including The Best of Bharat Awards 2022 by exchange4media in the year 2022, and Silver Medal from National Awards for Manufacturing Competitiveness Assessment 2021 instituted by International Research Institute for Manufacturing.

Mankind has a pan-India marketing presence, with a field force of 11,691 medical representatives and 3,561 field managers, as of December 31, 2022. They operate 25 manufacturing facilities across India and had 4,121 manufacturing personnel as of December 31, 2022.

As of December 31, 2022, the Company had a team of over 600 scientists and a dedicated in-house R&D center with four units located in IMT Manesar, Gurugram, Haryana and Thane, Maharashtra.

Mankind Pharma IPO Details

IPO Date Apr 25, 2023 to Apr 27, 2023
Listing Date May 9, 2023
Face Value ₹1 per share
Price ₹1026 to ₹1080 per share
Lot Size 13 Shares
Total Issue Size40,058,844 shares
(aggregating up to ₹4,326.36 Cr)
Offer for Sale40,058,844 shares of ₹1
(aggregating up to ₹4,326.36 Cr)
Issue Type Book Built Issue IPO
Listing At BSE, NSE

Mankind Pharma IPO Reservation

QIB Shares Offered8,011,769 (20.00%)
NII (HNI) Shares Offered6,008,827 (15.00%)
Retail Shares Offered14,020,596 (35.00%)
Anchor Investor Shares Offered12,017,652 (30.00%)
Total Shares Offered28,041,192
Total Shares With Anchor Investor40,058,844

Mankind Pharma IPO Anchor Investors Details

Mankind Pharma IPO Anchor Investors list

Bid Date Apr 24, 2023
Shares Offered 12,017,652
Anchor Portion Size (In Cr.) 1,297.91
Anchor lock-in period end date for 50% shares (30 Days) Jun 14, 2023
Anchor lock-in period end date for remaining shares (90 Days) Sep 8, 2023

Mankind Pharma IPO Timetable (Tentative)

Mankind Pharma IPO opens on Apr 25, 2023, and closes on Apr 27, 2023.

Event Tentative Date
Opening Date Tuesday, 25 April 2023
Closing Date Thursday, 27 April 2023
Basis of Allotment Wednesday, 3 May 2023
Initiation of Refunds Thursday, 4 May 2023
Credit of Shares to Demat Friday, 5 May 2023
Listing Date Tuesday, 9 May 2023
Cut-off time for UPI mandate confirmation 5 PM on Apr 27, 2023

Mankind Pharma IPO Lot Size

The Mankind Pharma IPO lot size is 13 shares.

Application Lots Shares Amount
Retail (Min) 1 13 ₹14,040
Retail (Max) 14 182 ₹196,560
S-HNI (Min) 15 195 ₹210,600
S-HNI (Max) 71 923 ₹996,840
B-HNI (Min) 72 936 ₹1,010,880
Lot Size Calculator

Mankind Pharma IPO Promoter Holding

Ramesh Juneja, Rajeev Juneja, Sheetal Arora, Ramesh Juneja Family Trust, Rajeev Juneja Family Trust, and Prem Sheetal Family Trust are the company promoters.

Pre Issue Share Holding 79.00%
Post Issue Share Holding 76.50%

Company Financials

Mankind Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-205,073.295,975.651,056.153,485.313,436.34126.92
31-Mar-216,372.636,385.381,293.034,722.004,674.39234.53
31-Dec-218,043.886,218.291,260.245,965.465,916.86268.70
31-Mar-229,147.747,977.581,452.966,155.236,106.06868.03
31-Dec-229,273.756,777.821,015.987,145.897,094.12167.93
Amount in ₹ Crore

Key Performance Indicator

KPI Values
P/E (x)32.5
Market Cap (₹ Cr.)43263.6
ROE27.6
ROCE26.1
EPS (Rs)33.2
RoNW (%)27.7

Objects of the Issue

The company will not receive any proceeds from the offer and all the offer proceeds will be received by the selling shareholders, in proportion to the offered shares sold by the respective selling shareholders as part of the offer.

Mankind Pharma IPO Review (May apply)

[Dilip Davda]  A major domestic player in healthcare products is going public with a pure vanilla OFS issue. It is diluting just 10% now. It has shown good financial performance from FY20 to FY22. The setback for 9m of FY23 is due to one-time provisioning for its recent takeovers. Based on recent performance, the issue appears fully priced. It’s a long race horse, hence investors may consider parking funds with a long-term perspective. Read detail review...


Mankind Pharma IPO Subscription Status (Bidding Detail)

The Mankind Pharma IPO is subscribed 15.32 times on Apr 27, 2023 7:02:00 PM. The public issue subscribed 0.92 times in the retail category, 49.16 times in the QIB category, and 3.80 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)
QIB49.16
NII3.80
    bNII (bids above ₹10L)4.99
    sNII (bids below ₹10L)1.41
Retail0.92
Total15.32

Total Application : 462,789 (0.43 times)

Mankind Pharma IPO Prospectus

Mankind Pharma IPO Rating

73
3.6
Rating:Rated 3.6 stars
Vote Here ...

Mankind Pharma IPO Listing Details

Listing Date May 9, 2023
BSE Script Code 543904
NSE Symbol MANKIND
ISIN INE634S01028
Final Issue Price ₹1080 per share

Pre-Open Session - NSE Pre-Open Session - BSE

Listing Day Trading Information

Price Details
Final Issue Price
Open
Low
High
Last Trade
BSE
₹1,080.00
₹1,300.00
₹1,300.00
₹1,430.00
₹1,424.05
NSE
₹1,080.00
₹1,300.00
₹1,300.00
₹1,430.00
₹1,080.00

Check IPO Performance…

Company Contact Information

Mankind Pharma Limited
208, Okhla Industrial Estate
Phase-III,
New Delhi 110020
Phone: +91 11 4684 6700
Email: investors@mankindpharma.com
Website: https://www.mankindpharma.com/

Mankind Pharma IPO Registrar

Kfin Technologies Limited

Phone: 04067162222, 04079611000
Email: mankind.ipo@kfintech.com
Website: https://karisma.kfintech.com/

Mankind Pharma IPO FAQs

Mankind Pharma IPO is a main-board IPO of 40,058,844 equity shares of the face value of ₹1 aggregating up to ₹4,326.36 Crores. The issue is priced at ₹1026 to ₹1080 per share. The minimum order quantity is 13 Shares.

The IPO opens on Apr 25, 2023, and closes on Apr 27, 2023.

Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Zerodha customers can apply online in Mankind Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Mankind Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Mankind Pharma IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Mankind Pharma IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. ‘Submit’ IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Mankind Pharma IPO opens on Apr 25, 2023 and closes on Apr 27, 2023.

Mankind Pharma IPO lot size is 13 Shares and the minimum order quantity is .

You can apply in Mankind Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Mankind Pharma IPO will be done on Wednesday, 3 May 2023, and the allotted shares will be credited to your demat account by Friday, 5 May 2023. Check the Mankind Pharma IPO allotment status.

The Mankind Pharma IPO listing date is on May 9, 2023.
Open an Instant Account with Zerodha

Mankind Pharma IPO Message Board

Ranked Members of Chittorgarh.com Forum  Ranked Members | Most Liked Members

Loading...

3236 Comments

1283. IPO KING MAKER |   Link |May 30, 2023 5:21:08 PM
Top Contributor Top Contributor (400+ Posts, 200+ Likes)
Anybody have data about result??????
1283.2. Sk Soni |   Link |May 30, 2023 11:51:41 PM
Mankind Pharma reports Q4 earnings.

Net profit up 50.2% at Rs 285.4 cr Vs Rs 190 cr (YoY)

Revenue up 19% at Rs 2,052.7 cr Vs Rs 1,752.8 cr (YoY)

EBITDA up 46.3% at Rs 416.7 cr Vs Rs 284.8 cr (YoY)

Margin at 20.3% Vs 16.5% (YoY)
1283.3. 👑 King HR |   Link |May 31, 2023 9:09:57 AM
New Member New Member
Good result
1282. Gaurav DD dimer |   Link |May 24, 2023 8:40:28 AM
IPO Mentor IPO Mentor (900+ Posts, 300+ Likes)
Results on 30th May.
1282.1. COOPER |   Link |May 30, 2023 9:47:57 AM
sir,
what is your expectation regarding result?
1281. VIKTG |   Link |May 22, 2023 10:29:24 AM
my position done and dusted at todays fall
1280. Kapz |   Link |May 18, 2023 11:05:30 PM
Top Contributor Top Contributor (200+ Posts, 100+ Likes)
AMFI will review the market cap categorisation and will issue the list in the first week of July. Mankind Pharma and few other stocks are expected to make an entry into Large Cap categorization leading to active Mutual fund managers to modify/ make additions to their portfolio positions
1279. Amit Kumar Yadav |   Link |May 17, 2023 10:06:42 AM
Top Contributor Top Contributor (600 Posts, 200+ Likes)
Kaynes flying high. doubled from IPO price
1278. COOPER |   Link |May 17, 2023 9:52:15 AM
Hello experts, what are your views on Mankind now??? sell or hold?
1277. newgen consultancy |   Link |May 11, 2023 11:11:04 PM (200+ Posts)
Jupiter hospitals files for a 1050 cr ipo
1276. Santosh IPO Investor |   Link |May 11, 2023 5:38:39 PM
Top Contributor Top Contributor (300+ Posts, 100+ Likes)
Mankind one can hold with 1300 as stoploss
1275. VIKTG |   Link |May 11, 2023 3:35:09 PM
aaj kiska kiska mal kat gya?
1275.1. jasbirsingh |   Link |May 11, 2023 4:39:15 PM
1300 seah niche jata toh shyad katne k sochta.
1274. Silent lion |   Link |May 11, 2023 10:37:48 AM
Ye IT raid wala game ho ga syd. Ratail ka mal niklavane k liye
1273. ManishDwiv |   Link |May 11, 2023 9:55:26 AM
Top Contributor Top Contributor (200+ Posts, 100+ Likes)
IT raid on mankind pharmaa
1273.5. Liger |   Link |May 11, 2023 10:22:24 AM
Top Contributor Top Contributor (200+ Posts, 400+ Likes)
The Income Tax (I-T) department conducted searches at Mankind Pharma's New Delhi offices, as per sources. The action is likely to continue for 1-2 days.
https://www.zeebiz.com/companies/news-i-t-raids-mankind-pharma-delhi-offices-share-price-nse-bse-slips-45-percent-latest-news-update-234446
1273.6. Santosh IPO Investor |   Link |May 11, 2023 5:27:24 PM
Top Contributor Top Contributor (300+ Posts, 100+ Likes)
News came to accumulate around 1300 to 1350 from market
1272. PRIMARY MARKET LEARNER |   Link |May 11, 2023 9:49:09 AM
IT Raid in Mankind Pharma Ofiice.
Now This Is To capture all shares of HNI and Retail.
1271. Earthking |   Link |May 10, 2023 10:58:19 PM
IPO Mentor IPO Mentor (700+ Posts, 200+ Likes)
Really surprised to see no mention of BULK deals yesterday and today in MANKIND ????? is there a possibility for this thing to happen???
1270. CLD |   Link |May 10, 2023 9:46:26 PM
Top Contributor Top Contributor (500+ Posts, 100+ Likes)
Delivery only 35% today on NSE. 1400 is cap for the time being till 1st qtr result.
1269. Are CIRCUIT |   Link |May 10, 2023 8:48:25 PM
@Admin @ Chittorgarh.com  image kaise upload hoti he please tell setps
I want to share my analysis made in excel via snapshot
1269.1. Ajaysinh Jadeja |   Link |May 10, 2023 9:06:34 PM
Only ipo Guru, top contributor and ipo mentor can upload images.
1268. Student. |   Link |May 10, 2023 4:24:06 PM
Top Contributor Top Contributor (400+ Posts, 200+ Likes)
Mankind's Business Model is Quite Intresting

Manforce agar Fail bhi Hua To Uska Result Dekhne Ke Liye Log Prega News Kharidenge

Aur Agar Manforce Pass Hua To Agli Baar Fir Manforce Ko hi Log Kharidenge

Dono Taraf se Fayda Hai Iss Company Ko
🙃
1267. tri.vis |   Link |May 10, 2023 2:05:50 PM
OT:
Harsha engineering today zoomed. Up more than 8%
Due to good results???
1267.1. PKRAJ |   Link |May 10, 2023 2:51:51 PM
IPO Guru IPO Guru (1100+ Posts, 600+ Likes)
Out of topic :
Dreamfolk going high. Positive more than 8%. Good news for those holding the shares.
1266. CSK |   Link |May 10, 2023 11:24:37 AM
Top Contributor Top Contributor (300+ Posts, 400+ Likes)
Sorry for Out Of topic query- Rsystem Delisting is failed.. Please suggest can tender share in open offer?
1266.3. UjwalG |   Link |May 10, 2023 1:13:12 PM (300+ Posts, 100 Likes)
Dont call me sir pls. Results were good and its already trading above 250. As i said, short term there could be supply pressure becasue many were hoping for quick 6-7%. I think should hold it with 6,8 months view. Also bhavook tripathi is known as the guy who removes every drop of juice from the stock. Rest its an individuals choice to hold as per fund availability. Good ipos are lined up
1266.4. CSK |   Link |May 10, 2023 1:42:40 PM
Top Contributor Top Contributor (300+ Posts, 400+ Likes)
Super Ji, Thanks for the update
1265. tri.vis |   Link |May 10, 2023 12:58:52 PM
OT :
Anyone has idea why Latentview falls more than 12% today??
1265.2. Param Patel |   Link |May 10, 2023 1:08:45 PM
Top Contributor Top Contributor (400+ Posts, 200+ Likes)
@tri.vis Very Poor result
1265.3. tri.vis |   Link |May 10, 2023 1:30:10 PM
Thanks for reply.
1264. PKRAJ |   Link |May 10, 2023 10:07:31 AM
IPO Guru IPO Guru (1100+ Posts, 600+ Likes)
Shares under pressure of selling. Opened at small higher price. Thereafter downtrend started. Now more than 4% down. In the beginning buyers were more and sellers were very less in number. Market was in green. But now in red. Now sellers are more and buyers are less in numbers.
Yesterday's unexpected very high listing and thereafter upper circuit, may be a reason of down trend today.
Better to sell if it goes below listing price. Till than holding will be good. Wait and watch strategy. Only my views.